At NeonMind Biosciences, we believe in “mind over matter”.
We plan to help people change their lives by changing their minds, through treatment with psychedelics.
Our first step is tackling one of the biggest health issues the world is facing right now: obesity.
Obesity accounts for
of the global burden of disease.
NeonMind is exploring psilocybin (found in psychedelic mushrooms) as an innovative treatment approach to weight loss through a preclinical trial.
We know that psilocybin is known to activate serotonin receptors, and that serotonin can curb cravings, shut off appetite, and reduce eating.
We are using our proprietary formulations to commercialize mushroom-infused functional food products.
The global market for functional mushrooms is forecasted to reach $34.3 billion by 2024.
Our NeonMind™ mushroom infused coffee commerce platform launched in November 2020 at www.neonmind.com and we are currently in revenues from direct to consumer sales of these products.
We’d love to hear from you.
Please fill out the form below to submit a question, join our mailing list or request more information about the company.
200 – 1238 Homer Street
Vancouver, BC V6B 2Y5
Endeavor Trust Corporation
Exvera Communications Inc.
©2021 NeonMind Biosciences Inc.
©2020 NeonMind Biosciences Inc.